Ovation is at the forefront of precision medicine, leveraging extensive human genomic and omics data to enhance drug discovery and development. The company offers a biobank containing approximately 1.6 million consented samples, which can be sequenced to generate valuable genomic data across over 60 predefined disease cohorts. This data includes whole genome sequencing, whole exome sequencing, and RNA sequencing, all linked to comprehensive clinical information. By integrating genomic data with phenotypic and clinical data, Ovation aims to significantly improve biomarker discovery, target identification, and patient stratification, ultimately increasing the success rates of drug development across various therapeutic areas.

In addition to its genomic data offerings, Ovation provides specialized solutions for clinical laboratories through its Ovation LIMS and the Ovation Research Network. The LIMS is designed to support molecular diagnostic laboratories in their critical functions, while the Research Network facilitates the mobilization of remnant samples for research purposes. This network allows diagnostic labs to contribute to life sciences research by providing access to their samples and associated clinical data, thereby generating additional revenue and accelerating the discovery of new treatments. By creating a comprehensive clinicogenomic database, Ovation empowers labs to participate in research initiatives that can lead to life-saving therapies, transforming the landscape of preclinical research.

United States

Ovation is a leading provider of genomic data for the life sciences industry. We are dedicated to supporting the advancement of precision medicine and offer access to a wide range of high-quality, consented genomic data linked to diverse, longitudinal phenotypic data at scale. Our data allows researchers to identify and validate biomarkers, discover new targets and understand resistance mechanisms in various populations. Our cloud-based LIMS system allows clinical labs to easily adopt innovative molecular tests, while also transforming samples into valuable research-grade data across various disease areas. Learn more at www.ovation.io.


Ovation

Company Details